Paragonix Develops Devices To Reduce Transplantation Transport-Related Failure

Keeping organs designated for transplantation cool is vital to ensure procedure success. Medtech Insight spoke to Paragonix’s CEO, Lisa Anderson, to learn more.

Paragonix has developed a range of organ transportation devices to tackle the structural and logistical challenges surrounding organ transplantation.

So far, the Cambridge, MA-based company has developed devices for transporting human hearts, lungs, livers, kidneys and pancreases

More from Surgery

More from Device Area